Dividends Calendar Earnings Calendar
EDIT

EDIT | Editas

Healthcare sector
Editas
Category: Pharmaceutical company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 864.19M
  • Prev closed:
  • Open: 15.61
  • High: 15.89
  • Low: 15.03
  • 52 week low: 15.03
  • 52 week high: 73.02
  • Dividends:No Dividends

Next ER: August 3, 2022  Before Market Opens



Top Stories (EDIT)



    About the Company

    Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPR–Cas9 gene editing technology. The company went public on 2 Feb 2016.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 9, 2022
    August 3, 2022-0.78 / -0.80826.4M / 4.29MBeat!
    May 4, 2022-0.74 / -0.78176.77M / 3.85MBeat!
    February 24, 2022-0.61 / -0.712212.47M / 4.64MBeat!
    November 8, 2021-0.57 / -0.81296.2M / 4.74MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 3, 2022 18.64 17.66
    19.40
    17.60
    		 2.61M 13.24%
    Aug 2, 2022 16.46 15.70
    16.73
    15.68
    		 1.21M 3.91%
    Aug 1, 2022 15.84 15.71
    16.72
    15.67
    		 1.29M -0.44%
    Jul 29, 2022 15.91 16.41
    16.41
    15.54
    		 1.20M -2.99%
    Jul 28, 2022 16.40 17.03
    17.19
    16.17
    		 1.25M -2.61%
    Jul 27, 2022 16.84 16.59
    16.91
    15.77
    		 1.66M 3.69%
    Jul 26, 2022 16.24 16.15
    16.98
    15.57
    		 1.69M -0.67%
    Jul 25, 2022 16.35 16.04
    16.42
    15.30
    		 1.34M 2.51%
    Jul 22, 2022 15.95 17.27
    17.38
    15.91
    		 1.68M -6.45%
    Jul 21, 2022 17.05 17.30
    17.60
    16.76
    		 1.01M -2.07%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2013
    • Employees:89

    News

    News for (EDIT)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Katrine S. Bosley

    Talk about Editas below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 3, 2022 (Same day)

    ea gddy tm hmc mgm rmax fox lamr edit vale pbr meli 


    Jump to (Finance sites)

    Google   
             

    Research 


    Investor page

    ir.editasmedicine.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 33
    HOLD 42
    SELL 25

    Their Official Profiles 

    WikipediaTwitterLinkedIn

    Peers / Similar stocks 

    xlv 

    Other stocks 

    pg wfc orcl hrl rost wmb sptn schw bkng ostk tal mrvl 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet